Back

Hypertension, obesity, and aldosterone in women: role of adipocyte dysregulation

28 August 2026 (15:25 - 15:33)
Organised by: Logo
Congress Presentation Part of: Hypertension in women: time to address the unmet clinical need Hypertension Open Access ESC Congress 2026 European Society of Cardiology

5 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor R. Touyz (Montreal, CA)
Presentation thumbnail
Hypertension and cardio-renal-metabolic syndrome risk in women: unmet clinical need
Doctor M. Saxena (London, GB)
Presentation thumbnail
Sexual dimorphism of hypertension: interplay between sex hormones and aldosterone
Professor E. Michos (Baltimore, US)
Presentation thumbnail
Persistent sub-optimal control of hypertension despite treatment - case-based panel discussion
Presentation thumbnail
Hypertension in women: time to address the unmet clinical need - Q&A and closing remarks

Access the full session

Session thumbnail
Hypertension in women: time to address the unmet clinical need

The Event

Event poster

ESC Congress 2026

28 August 2026 15:25 CET
You may be interested in
thumbnail
Congress Session
Does aldosterone synthase inhibition hold a key to transforming cardiorenal care?
19 May 2025
thumbnail
Congress Presentation
Differences between non-obese and obese patients with hypertension according to gender
14 June 2024
thumbnail
Congress Session
Adiposity and the heart (4)
31 August 2026
thumbnail
Congress Presentation
Mechanisms involved in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity
20 April 2018

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources